Prostaglandins 1982-09-01

Metabolism of the prostaglandin fertility regulator sulprostone in monkeys.

F C Falkner

Index: Prostaglandins 24(3) , 341-50, (1982)

Full Text: HTML

Abstract

The prostaglandin imide analog sulprostone (I) was labeled with tritium in the phenoxy ring to trace the fate of the prostanoic acid portion of the molecule and with carbon-14 in the methanesulfonimide moiety to trace the fate of that portion of the molecule. Disposition was studied after intravenous administration to female cynomolgus monkeys. The excretion and plasma pharmacokinetics of total radioactivity indicated that the prostanoic acid and methanesulfonimide moieties were disposed of differently, implying that hydrolysis of sulprostone was extensive and that the hydrolysis products were treated independently. The urinary excretion of tritium (prostanoic acid) was consistent with that observed for other prostaglandins. The urinary excretion and plasma pharmacokinetics of carbon-14 were consistent with those expected for methanesulfonamide. Urinary metabolites identified in 0-2 hr urine included a trace amount of unchanged drug, methanesulfonamide, and two products of beta-oxidation - the tetranor and dihydrotetranor prostanoic acids.


Related Compounds

  • Methanesulfonamide

Related Articles:

Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.

2015-01-01

[Arthritis. Res. Ther. 17 , 321, (2015)]

Inhibition of cyclooxygenase-2 causes a decrease in coronary flow in diabetic mice. The possible role of PGE2 and dysfunctional vasodilation mediated by prostacyclin receptor.

2015-09-01

[J. Physiol. Biochem. 71 , 351-8, (2015)]

In vitro antitumor mechanism of (E)-N-(2-methoxy-5-(((2,4,6-trimethoxystyryl)sulfonyl)methyl)pyridin-3-yl)methanesulfonamide.

2015-01-01

[Mol. Pharmacol. 87(1) , 18-30, (2015)]

Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agents.

2012-03-01

[Eur. J. Med. Chem. 49C , 397-405, (2012)]

Hepatic protein tyrosine phosphatase 1B (PTP1B) deficiency protects against obesity-induced endothelial dysfunction.

2014-12-15

[Biochem. Pharmacol. 92(4) , 607-17, (2014)]

More Articles...